Identification of new therapeutic targets in CRLF2-overexpressing B-ALL through discovery of2 TF-gene regulatory interactions.
Sana Badri, Beth A. Carella, Priscillia Lhoumaud…·Jane A. Skok
The paper identifies new therapeutic targets in CRLF2-overexpressing B-ALL by analyzing TF-gene regulatory interactions using network inference and experimental validation.